Sentence examples for points of presentation from inspiring English sources

But Alexander was also on message, defending a string of contentious economic decisions as well as demonstrably silly points of presentation, including the chancellor and prime minister's repeated claims that Britain had been teetering, Greek-style, on the edge of bankruptcy before the axemen saved the day.

To evaluate the association between pretreatment serum EPCA levels and the disease progression, we assessed the changes of serum EPCA levels at the time points of presentation prior to treatment between patients with disease progression and those without.

The samples were chosen to represent the time points of presentation prior to treatment, the first evidence of PSA increase beyond the normal range and disease progression.

Other points of presentation that need attention: a) The conclusion that "membrane anchoring of the receptor is required to maintain the level of signal strength necessary for postnatal maturation of the synapse" seems to be a misinterpretation.

They should collect standardised data and radiological investigations at the point of presentation and relate them to the outcome of the case.

Inclusion criteria were the availability of complete sets of MRIs with STIR and T1-post-Gd sequences and of conventional radiographs (see below) at the time point of presentation (BL) and after 2 years of follow-up (2yFU).

While biomarker scores can be highly accurate and are scientifically attractive, they are not useful at the point of presentation as the assays on which they depend take time to run.

Although plain x-rays may be ordered by primary care clinicians, the decision to do so appears to be determined less by clinical features at the point of presentation as by provider characteristics and other considerations such as patient expectations of a diagnosis or a predetermined management plan [ 11, 12].

For this analysis we merged the reactivations detected by MVPCs trained at different time points of sample presentation (i.e., from 44 to 764 ms after the onset of sample presentation) and calculated PLVs to theta, considering theta recordings of each of the 275 MEG sensors separately.

No correlation between the total number of pretreatments (i.e. ranibizumab and/or bevacizumab) and the change in maximum height of the PED could be observed (Spearman's rho = 0.121, p  = 0.278) as shown in the point by point presentation of "number of prior treatments" and "change in maximum PED height" in Fig.  1b.

DiDonato is always communicative, adept at the finer points of concert presentation.